Literature DB >> 19414351

Oestrogen-synthesising enzymes and breast cancer.

Myutan Kulendran1, Mohamed Salhab, Kefah Mokbel.   

Abstract

There is a large and compelling body of epidemiological and experimental evidence that oestrogens are the fuel behind the aetiology of breast cancer. The carcinogenic effects of oestrogen are postulated to be mediated by: the stimulation of cellular proliferation through their receptor-mediated hormonal activity. Other mechanisms include; direct genotoxic effects by increasing mutation rates through a cytochrome P450-mediated metabolic activation and induction of aneuploidy. The local biosynthesis of oestrogens, especially in postmenopausal women as a result of the interactions of various enzymes, is believed to play a very important role in the pathogenesis and development of hormone dependent breast carcinoma. The over-expression of such enzymes seems to be associated with the development of a more aggressive disease process, a poorer outcome and increased local and distant recurrences.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414351

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  Molecular therapy of breast cancer: progress and future directions.

Authors:  Sheng-Xiang Lin; Jiong Chen; Mausumi Mazumdar; Donald Poirier; Cheng Wang; Arezki Azzi; Ming Zhou
Journal:  Nat Rev Endocrinol       Date:  2010-07-20       Impact factor: 43.330

2.  The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women.

Authors:  Kristine R Monroe; Frank Z Stanczyk; Kathleen H Besinque; Malcolm C Pike
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

3.  Polymorphisms in genes involved in the estrogen pathway and mammographic density.

Authors:  Isabelle Dumas; Caroline Diorio
Journal:  BMC Cancer       Date:  2010-11-22       Impact factor: 4.430

4.  Serum glucose and risk of cancer: a meta-analysis.

Authors:  Danielle J Crawley; Lars Holmberg; Jennifer C Melvin; Massimo Loda; Simon Chowdhury; Sarah M Rudman; Mieke Van Hemelrijck
Journal:  BMC Cancer       Date:  2014-12-19       Impact factor: 4.430

5.  Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer.

Authors:  Jianzong Li; Haiyang Wang; Junjie Li; Jinku Bao; Chuanfang Wu
Journal:  Int J Mol Sci       Date:  2016-07-01       Impact factor: 5.923

Review 6.  Adiposity, breast density, and breast cancer risk: epidemiological and biological considerations.

Authors:  Ludivine Soguel; Francine Durocher; André Tchernof; Caroline Diorio
Journal:  Eur J Cancer Prev       Date:  2017-11       Impact factor: 2.497

7.  Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells.

Authors:  Sangyun Shin; Hee-Jung Im; Yeo-Jung Kwon; Dong-Jin Ye; Hyoung-Seok Baek; Donghak Kim; Hyung-Kyoon Choi; Young-Jin Chun
Journal:  Oncotarget       Date:  2017-06-27

8.  Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study.

Authors:  D M Fraser; F M Sullivan; A M Thompson; C McCowan
Journal:  Br J Cancer       Date:  2014-06-19       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.